kelatine 300 mg comprimido revestido - Keresési eredmények

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

agomelatine lupin agomelatine (as agomelatine-citric acid) 25 mg film-coated tablet blister pack

southern cross pharma pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty 25 mg) - tablet, film coated - excipient ingredients: mannitol; silicified microcrystalline cellulose; sodium stearylfumarate; colloidal anhydrous silica; povidone; crospovidone; magnesium stearate; stearic acid; hypromellose; macrogol 6000; titanium dioxide; purified talc; iron oxide yellow - treatment of major depression in adults including prevention of relapse.

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

gelatin

ranvet pty. limited - gelatin - unknown - gelatin filler active 0.0 - active constituent

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

gelofusine succinylated gelatin 40g/1000ml injection bag.

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a collodial plasma volume substitute in: 1. treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidual or spinal anaesthesia, non-hypovolaemic shock. 2.hacmodilution (perioperative, therapeutic venesection). 3.extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

gelofusine succinylated gelatin 20g/500ml

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a collodial plasma volume substitute in:treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidural or spinal anaesthesia, non-hypovolaemic shock. 2.haemodilution (perioperative, therapeutic venesection); 3.extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

gelofusine succinylated gelatin 20g/500ml injection bottle

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a colloidal plasma volume substitute in: 1. treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidural or spinal anaesthesia,non-hypovolaemic shock. 2. haemodilution (perioperative, therapeutic venesection); 3. extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).